Additional file 1 of MEX3C as a potential target for hepatocellular carcinoma drug and immunity: combined therapy with Lenvatinib

Authors
Publication date
12 October 2023
Publisher
Doi

    Abstract

    Supplementary Material

      Similar works

      Full text

      thumbnail-image

      Available Versions

      FigShare

      redirect
      oaioai:figshare.com:article/24303...
      Last time updated on 04/11/2023